Levels of circulating intercellular adhesion molecule-1 and -3 but not circulating endothelial leucocyte adhesion

Related Experiment Videos

A E Voskuyl1, S Martin, L Melchers

  • 1Department of Rheumatology, University Hospital, Leiden, The Netherlands.

Insights

Circulating intercellular adhesion molecule-1 (cICAM-1) and cICAM-3 levels are elevated in rheumatoid vasculitis (RV), indicating vascular inflammation. These markers may aid in diagnosing RV, distinguishing it from rheumatoid arthritis.

Area of Science:

  • Immunology
  • Rheumatology
  • Vascular Biology

Background:

  • Rheumatoid vasculitis (RV) is a severe complication of rheumatoid arthritis (RA).
  • Vascular inflammation is a key feature of RV.
  • Biomarkers for assessing vascular inflammation in RV are needed.

Purpose of the Study:

  • To investigate if circulating adhesion molecules reflect vascular inflammation in RV.
  • To compare levels of specific adhesion molecules in RV patients, RA patients, and healthy donors.

Main Methods:

  • Quantification of circulating intercellular adhesion molecule-1 (cICAM-1), cICAM-3, and circulating endothelial leucocyte adhesion molecule (cE-selectin) using enzyme-linked immunosorbent assays.
  • Comparison of adhesion molecule levels between 14 RV patients, 47 RA patients, and 100 healthy donors.

Main Results:

  • RV patients exhibited significantly elevated levels of cICAM-1 and cICAM-3 compared to RA patients (P < 0.0001).
  • Elevated cICAM-1, cICAM-3, and cE-selectin were found in 57%, 71%, and 21% of RV patients, respectively.
  • 43% of RV patients showed increased levels of both cICAM-1 and cICAM-3, unlike RA patients.
  • cICAM-3 levels were significantly lower in the inactive phase of RV.

Conclusions:

  • Circulating ICAM-1 and ICAM-3 levels may serve as useful markers for vascular inflammation in rheumatoid vasculitis.
  • These adhesion molecules could potentially aid in the diagnosis and monitoring of RV.

Related Concept Videos